Plus   Neg

Barratt Developments Says Trading Strong; FY View In Line With Board's Outlook

UK home builder Barratt Developments Plc. (BDEV.L), in its trading update for the period from January 1 to May 6, said its trading is strong and the outlook for the full year remains in line with the Board's expectations.

Sales rate is in line with the prior year at 0.80 net private reservations per active outlet per average week.

Total forward sales, including Jvs, was up 2.5% as at May 6 to 3.29 billion pounds.

The company said it expects to approve the purchase of more than 20,000 plots for the full year to help support future volume growth, compared to last year's 18,497 plots.

David Thomas, Chief Executive, said, "Trading since the beginning of the year has been strong across the country driven by good customer demand for our high quality new homes and an attractive lending environment. We have a healthy forward order book and a robust balance sheet.... we continue to focus on growing our housing output, creating jobs and supporting economic growth across the country."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
J. M. Smucker Co. is recalling certain Natural Balance canned cat food, citing health concerns likely associated with increased levels of choline chloride, an animal growth promotant, the U.S. Food and Drug Administration said in a statement. The recall was initiated after receiving reports of adverse reactions. Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19.
Follow RTT